Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 63

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 63
---
 operational plans which have not yet been developed and which may vary from past experiences operating the same assets or recent experiences operating in the same areas). If Clearwater is not able to realize the anticipated benefits expected from the Transactions within the anticipated timing or at all, Clearwater’s business, financial position, results of operations and cash flows may be adversely affected, Clearwater’s earnings per share may be diluted, the accretive effect of the Transactions may decrease or be delayed and the market price of Clearwater Common Stock may be negatively impacted. The integration of the two companies will require significant time and focus from management following the Transactions and could result in performance shortfalls as a result of the diversion of management’s attention to such integration efforts. Difficulties in integrating Enfusion into Clearwater may result in the combined company performing differently than expected, in operational challenges or in the failure to realize anticipated benefits, including anticipated operational and other synergies between the two companies, in whole or in part, on the anticipated timeline or at all. Potential difficulties that may be encountered in the integration process include:

| • |     | complexities associated with managing a larger, more complex, integrated business; |

| • |     | potential unknown liabilities and unforeseen expenses associated with Enfusion and its integration into 
 Clearwater;                                                                                             |

| • |     | potential unknowns with respect to future operational plans; and |

| • |     | inconsistencies between the two company’s standards, controls, procedures and policies. |

In addition, Clearwater’s business may be negatively impacted following the Transactions if it is unable to effectively manage the expanded operations of the combined company. Actual growth and any potential cost savings, if achieved, may be lower than what Clearwater and Enfusion expect and may take longer to achieve than anticipated. If Clearwater and Enfusion are not able to adequately address integration challenges, they may be unable to successfully integrate their operations or realize the anticipated benefits of the integration of the two companies. Clearwater and Enfusion, including their respective subsidiaries, have operated and, until the completion of the Merger, will continue to operate independently. It is possible that the pendency of the Merger, as well as the integration process, could result in the loss of key personnel, the loss of customers, inconsistencies in standards, controls, procedures and policies, unexpected integration issues, higher than expected integration costs, an overall post-completion integration process that takes longer than originally anticipated, as well as the disruption of each company’s ongoing businesses. Any or all of those occurrences could